Applications Published 20 September 2000

Published: 26-Mar-2001

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Compsns for nasal administration
    West Pharmaceutical Services Drug Delivery and Clinical Research Centre 1035833*

  • Osmotic dosage form comprising first and second coats
    Alza Corp 1035834*

  • Long acting injectable formualtions containing hydrogenated castor oil
    Merck & Co 1035835*

  • Improved method for avoiding the degradation of an active principle
    Capsulis, Chateau Bersol 1035836*

  • Lipid compsns and their use
    Phares Pharmaceutical Research 1035837*

  • Pharmaceutical suspension tablet compsns
    FMC Corp 1035838*

  • Implantable gas propelled beneficial agent delivery device
    Ceramatec 1035839*

  • Sustained release formulation containing three different types of polymers and tablet formed therefrom
    Duramed Pharmaceuticals 1035840*

  • Method for producing solid dosing forms
    BASF 1035841*

  • Improved HMG CoA reductase inhibitor extended release formulation
    Andrx Pharmaceuticals 1035842*

  • 1-H-modulators
    Akzo Nobels 1035843*

  • The use of polyols in combating yeast infection and polyol preparations for said use
    Xyrofin Oy 1035844*

  • Modulators of cysteine protease
    Arad, Dorit 1035845*

  • Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
    Galderama SA 1035846*

  • Stable solution of zinc and bicarbonate ions
    Church & Dwight Company 1035847*

  • Substituted alkanohydroxamic acids and method of reducing TNF-alpha levels
    Celgene Corp 1035848*

  • Inhibitors of farnesyl-protein transferase
    Marck 1035849*

  • Method of combating obesity
    Knoll 1035851*

  • Use of F prostanoid receptor agonists for treating a bone disorder
    Procter & Gamble 1035853*

  • Use of alpha-glucosidase inhibitors for treating high-risk impaired glucose tolerance
    Takeda Chemical Industry 1035854*

  • Process for the surface modification of a polymer substrate and polymers formed therefrom
    Pharmacia & Upjohn 1035855*

  • Isolated DNA encoding human H3 histamine receptor
    Ortho-McNeil Pharmaceutical 1035856*

  • Oral anioxidant preparation comprising selenium and reduced glutathione
    Thione International 1035857*

  • Use of ginkgo biloba extracts for preparing a medicine
    Societe de Conseils de Recherches et d-Applications Scientifiques (SCRAS) 1035858*

  • The use of phospholipid complexes od extracts of $I(Vitis vinifera) as antiatherosclerotic agents
    Indena SpA 1035859*

  • Non-toxic immune stimulating enterotoxin compsns
    Idaho Research Foundation 1035860*

  • Threonine-containing protegrins
    Intrabiotics Pharmaceuticals 1035861*

  • Cyclosporin-containing microemulsion preconcentrate compsn
    Chong Kun Dang 1035862*

  • An over-expressing homologuous antigen vaccine and a method of making the same
    Viginia Tech Intellectual Properties 1035863*

  • Methods and compsns for the treatment of psoriasis
    University of Kentucky Research Foundation 1035864*

  • HIV-1 TAT, or derivatievs thereof for prophylactic and therapeutic vaccination
    Istituto Superiore di Sanita 1035865*

  • Mixed lipopeptide micelles for inducing an immune response and their therapeutic uses
    Institut National de la Sante et de la Recherche Medicale (INSERM) 1035866*

  • Trandermal delivery of particulate vaccine compsns
    Powderject Vaccines 1035867*

  • Use of a fibrinogen receptor-antagonists for preventing disseminated intravascular coagulation
    Wiemann-Gundula 1035868*

  • Chemical and thermally stable norastemizole formulations
    Sepracor 1035869*

  • Compsns and methods for treatment of hepatitis C virus-associated diseases
    Isis Pharmaceuticals 1035870*

  • Oxidative method for attachment of glycoproteins of glycopeptides to surfaces of medical devices
    Medtronic 1035871*

  • UV disinfection device
    a.c.k. aqua concept 1035872*

  • Sterilising container
    Wagner GmbH 1035873*

  • Adamantane derivatives
    AstraZeneca 1036059*

  • Cyclohexadiene derivatives as pesticides
    Novartis 1036060*

  • New compounds
    AstraZeneca 1036061*

  • Hydroxamic acid derivatives as matrix metalloprotease inhibitors
    Pfizer 1035062*

  • Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
    3-Dimensional Pharmaceuticals 1036063*

  • Selective beta-3-adrenergic agonists
    Eli Lilly 1036064*

  • Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors
    Allergan Sales 1036065*

  • Substituted pyrimidine and pyridine herbicides
    EI du Pont de Nemours 1036066*

  • PDGF receptor kinase inhibitory compounds, their preparation and compsns
    Yissum Research Development Compnay of the Hebrew University of Jerusalem 1036067*

  • Process and intermediates for the preparation of a triazoline herbicide
    FMC 1036068*

  • Benzenesulphonamide compounds
    Pharmacia & Upjohn 1036069*

  • N-alkyl ammonium acetonitrile salts, method s therefor and compsns therewith
    The Clorox Company; BASF 1036070*

  • Synthesis of 5,5'-diformul-2-2'difuran and derivatives thereof
    Ilovo Sugar 1036071*

  • Thrombin receptor antagonists
    Schering 1036072*

  • Benzodioxan, benzofuran or benzopyran derivatives having fundic relaxation properties
    Janssen Pharmaceutica 1036073*

  • S-oxide and S,S-dioxide tetrahydrothiopyran phenoxazolidinones
    Pharmacia & Upjohn 1036074*

  • Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidaemia and antihypertensive properties
    Dr Reddy's Research Foundation; Reddy-Cheminor 1036075*

  • Novel compounds
    AstraZeneca 1036076*

  • Photochromic pyrano-fused naphthopyrans
    Transitions Optical 1036077*

  • Thienopyrimidines
    Merck 1036078*

  • Method for alkylating elemental phosphor
    Clariant 1036079*

  • Method for producing dialkylphosphonic acid salts
    Clariant 1036080*

  • Heterocyclyl ligand containing ruthenium and osmium catalysts
    Ciba Speciality Chemicals 1036081*

  • Isolation of nucleic acids
    DNA Research Instruments 1036082*

  • Novel 3,6-hemiketals from the class of 9a-azalides
    Pliva Farmaceutska Industrija 1036083*

  • Chemical syntehsis of 6-O-alkyl erythromycon C
    Abbott Laboratories 1036084*

  • Self-addressable self-assembling microelectronic integrated systesm, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics
    Nanogen 1036085*

  • Caspase-14 polypeptides
    Human Genome Sciences 1036086*

  • Secreted proteins and polynucelotides encodingt hem
    Genetics Institute 1036087*

  • Method fo preparing 16 alpha,17 Alpha-dialkylated steroids
    Alcon Laboratories 1036088*

  • Wound healing compsns
    University of Southern California 1036089*

  • Echinocandin derivatievs, preparation thereof and application as anti-fungal agents
    Hoechst Marion Roussel 1036090*

  • 5T4 tumour-associated antigen for use in tunour immunotherapy
    Oxford Biomedica 1036091*

  • Hydrophobically-modified protein compsns and methods
    Biogen 1036092*

  • Conjugates useful in the treatment of prostate cancer
    Merck 1036093*

  • CYP7 promoter-binding factors
    Tularik; Sumitomo Pharmaceuticals 1036094*

  • Oxygen-transporting albumin-basde blood replacement compsn and blood volume expander
    New Century Pharmaceuticals 1036095*

  • Chondrocyte-like cells useful for tissue engineering and methods
    The Regents of the University of California 1036161*

  • Engraftable neural progenitor and stem cells for brain tumour therapy
    The Children's Medical Center 1036162*

  • Differentiation of adipose stromal cells into osteoblasts and uses thereof
    Zen Bio 1036163*

  • Buccal, non-polar spray
    Flemington Pharmaceutical Corp 1036561

  • Soft-pellet drug and process for the preparation thereof
    Fujisawa Pharmaceutical 1036562

  • Delayed-release oral formulation of dihydroxy open acid simvastin and salts and esters thereof
    Merck 1036564

  • Thyromimetic antiobesity agents
    Pfizer Products 1036564

  • Preventatives/remedies for diabetes
    Institute of Medicinal Molecular Design 1036565

  • Preparation for continuous intravenous administration
    Sumitomo Pharmaceuticals 1036566

  • Method and device for preparing a constant dose of medication administered by inhalation with low flow
    GSF – Forschungszentrum fur Umwelt und Gesundheit 1036569

  • A process for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative
    Mitsui Chemicals 1036793

  • 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compsns containing the same, and intermediates thereof
    Dainippon Pharmaceutical 1036794

  • Process for preparing ascorbic acid-2-monophosphate salt
    Showa Denko 1036795

  • Method for producing phosphabenzene compounds
    BASF 1036796

  • Crystalline anthracycline antibiotic and process for producing the same
    Mercian Corp 1036797

  • Peptides having anti-cell adhesion activity
    Hisamitsu Pharmaceutical 1036798

  • Cellulose dispersion
    Asahi KK 1036799
    See more

    • You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    Read more
    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

    Trending Articles

    1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
    2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
    3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
    4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
    5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

    Upcoming event

    Enhancing probiotic stability through smarter formulation and packaging strategies

    18 September 2025 | Virtual     See all

    You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
    Manufacturing

    Sapio Sciences introduces world’s first 3rd-generation ELN

    Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
    Manufacturing

    Signal Group launches MCERTS approved VOC emissions monitor

    New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
    Research & Development

    Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

    The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
    You need to be a subscriber to read this article.
    Click here to find out more.
    Packaging

    Cloud labelling and serialisation: the new frontline of traceability in drug delivery

    As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
    Manufacturing

    Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

    The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
    Manufacturing

    L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

    Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
    Subscribe now